Avid Bioservices Announces Resignation of Chief Financial Officer
February 26 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a company
working to improve patient lives by providing high quality
biologics manufacturing services to biotechnology and
pharmaceutical companies, today announced that on February 23,
2018, Paul J. Lytle notified the company of his intent to resign
his position as chief financial officer, effective May 24, 2018, to
spend more time with his family prior to returning to work in the
drug development sector. A search for Mr. Lytle’s replacement
has been initiated, and Mr. Lytle will support the transition.
“Paul has been a principal member of management
for over 20 years, and his leadership was critical in the founding
of the company’s contract development and manufacturing business in
2002,” said Roger Lias, Ph.D., president and chief executive
officer of Avid Bioservices. “We are grateful for Paul’s
many contributions to Avid and we wish him well in his future
endeavors.”
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract development
and manufacturing organization (CDMO) focused on development and
cGMP manufacturing of biopharmaceutical products derived from
mammalian cell culture. The company provides a comprehensive
range of process development, high quality cGMP clinical and
commercial manufacturing services for the biotechnology and
biopharmaceutical industries. With nearly 25 years of
experience producing monoclonal antibodies and recombinant proteins
in batch, fed-batch and perfusion modes, Avid's services include
cGMP clinical and commercial product manufacturing, purification,
bulk packaging, stability testing and regulatory strategy,
submission and support. The company also provides a variety
of process development activities, including cell line development
and optimization, cell culture and feed optimization, analytical
methods development and product characterization.
www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024